Guselkumab
3 NDCs across 1 manufacturer|0 Generic,3 Brand
Guselkumab is used to treat psoriasis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $619 million on Guselkumab across 46,000 claims for 11,000 beneficiaries.
Guselkumab is available as 3 NDCs from 1 manufacturer (0 generic, 3 brand), with NADAC prices from $7318.99 to $14745.84 per ML — the most expensive product costs about 2.0× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
0G / 3B
Manufacturers
1
competing in market
Price Spread
$7318.99 – $14745.84
per ML
7d Activity
avg +0.1% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing GUSELKUMAB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TREMFYA 100 MG/ML ONE-PRESS | $14745.8421 per ML | +0.24% |
TREMFYA 100 MG/ML SYRINGE | $14728.9053 per ML | +0.09% |
TREMFYA 200 MG/2 ML PEN | $7318.9883 per ML | +0.12% |
Frequently Asked Questions
What is Guselkumab used to treat?
Guselkumab is used to treat psoriasis, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Guselkumab?
In 2024, Medicare Part D spent $619 million on Guselkumab across 46,000 claims for 11,000 beneficiaries.
How many Guselkumab products are on the market?
The Guselkumab drug market contains 3 NDCs from 1 manufacturer — 0 generic and 3 brand products.
What is the price range for Guselkumab?
NADAC reference prices for Guselkumab range from $7318.9883 to $14745.8421 per ML — the most expensive product costs about 2.0× the cheapest.
Which manufacturers make Guselkumab?
1 manufacturer lists Guselkumab in NADAC. Ranked by number of NDCs, the largest are Janssen Biotech, Inc. (3).
How has the price of Guselkumab changed recently?
Over the past 7 days, 3 Guselkumab NDCs rose and 0 fell, with a market-wide average change of +0.1%.